PD-L1 expression was neither significantly correlated with HER2 gene amplification in the tumor (TPS, p = 0.69), nor in TILs (IC, p = 0.76) with three of the four HER2-positive cases completely lacking tumoral PD-L1 expression. This evidence concerns the gene ERBB2 and neoplasm.